Gennex Laboratories [GENNEX] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Gennex Laboratories Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Gennex Laboratories Ltd. wins in 5 metrics, Divi's Laboratories Ltd. wins in 14 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Gennex Laboratories Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 14.37 67.11 Gennex Laboratories Ltd.
Price-to-Book Ratio 1.19 10.82 Gennex Laboratories Ltd.
Debt-to-Equity Ratio 39.79 0.58 Divi's Laboratories Ltd.
PEG Ratio -7.90 4.63 Divi's Laboratories Ltd.
EV/EBITDA 16.60 48.63 Gennex Laboratories Ltd.
Profit Margin (TTM) 12.59% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 13.54% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 13.54% 29.65% Divi's Laboratories Ltd.
Return on Equity 9.31% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 7.08% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-197.44M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -15.32% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 1.68 16.18 Gennex Laboratories Ltd.
Enterprise Value $3.08B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 2.03 15.86 Gennex Laboratories Ltd.
Gross Profit Margin (TTM) 29.90% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $6 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $0.73 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.60 0.19 Divi's Laboratories Ltd.

Gennex Laboratories Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

GENNEX
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Gennex Laboratories Ltd.-1.42%-5.86%9.27%3.17%-21.03%-24.98%
Divi's Laboratories Ltd.0.67%-3.25%-0.65%4.12%1.88%3.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Gennex Laboratories Ltd.-15.32%75.15%88.92%58.41%864.75%897.46%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Gennex Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricGENNEXDIVISLAB
Market Information
Market Cap i₹2.50B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i401,772253,443
90 Day Avg. Volume i626,792283,911
Last Close₹11.08₹6,576.50
52 Week Range₹7.05 - ₹17.25₹5,636.50 - ₹7,071.50
% from 52W High-35.77%-7.00%
All-Time High₹29.00 (Sep 16, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-61.79%-7.00%
Growth Metrics
Quarterly Revenue Growth0.07%0.12%
Quarterly Earnings Growth0.13%-0.01%
Financial Health
Profit Margin (TTM) i0.13%0.24%
Operating Margin (TTM) i0.14%0.30%
Return on Equity (TTM) i0.09%0.15%
Debt to Equity (MRQ) i39.790.58
Cash & Liquidity
Book Value per Share (MRQ)₹8.78₹580.95
Cash per Share (MRQ)₹1.98₹122.95
Operating Cash Flow (TTM) i₹-75,467,000₹19.67B
Levered Free Cash Flow (TTM) i₹181.23M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend i₹0.00₹60.00

Valuation & Enterprise Metrics Analysis: Gennex Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricGENNEX (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i14.3767.11
Forward P/E iN/A53.75
PEG Ratio i-7.904.63
Price to Sales (TTM) i1.6816.18
Price to Book (MRQ) i1.1910.82
Market Capitalization
Market Capitalization i₹2.50B₹1.69T
Enterprise Value i₹3.08B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i2.0315.86
Enterprise to EBITDA i16.6048.63
Risk & Other Metrics
Beta i0.600.19
Book Value per Share (MRQ) i₹8.78₹580.95

Financial Statements Comparison: Gennex Laboratories Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGENNEX (2025)DIVISLAB (2025)
Revenue/Sales i1.38B93.25B
Cost of Goods Sold i982.23M38.70B
COGS % of Revenue i71.4%41.5%
Gross Profit i393.29M54.55B
Gross Margin i28.6%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i147.25M25.71B
Operating Margin i10.7%27.6%
EBITDA i271.66M33.19B
EBITDA Margin i19.7%35.6%
Pre-Tax Income i215.47M29.16B
Pre-Tax Income % of Revenue i15.7%31.3%
Income Tax i32.75M7.25B
Income Tax % of Revenue i2.4%7.8%
Net Income (Profit) i181.23M21.91B
Profit Margin i13.2%23.5%

Balance Sheet & Liquidity Metrics

MetricGENNEX (2025)DIVISLAB (2025)
Cash & Equivalents i545.89M4.15B
Total Current Assets i1.81B100.81B
Total Current Assets % of Revenue i131.7%108.1%
Total Current Liabilities i445.55M14.52B
Total Current Liabilities % of Revenue i32.4%15.6%
Long-Term Debt i168.93M20.00M
Long-Term Debt % of Revenue i12.3%0.0%
Total Shareholders Equity i1.95B149.69B
Retained Earnings i562.59M134.00B
Retained Earnings % of Revenue i40.9%143.7%
Property, Plant & Equipment i88.69M3.19B

Cash Flow Statement Comparison

MetricGENNEX (2025)DIVISLAB (2025)
Operating Cash Flow i-75.47M19.67B
Operating Cash Flow % of Revenue i-5.5%21.1%
Capital Expenditures i-87.47M-14.38B
Free Cash Flow i-197.44M2.15B
FCF Margin i-14.4%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGENNEXDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i242.95M265.47M
Float Shares i156.62M117.72M
% Held by Insiders i33.66%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i66.34%19.31%

Dividend Analysis & Yield Comparison: Gennex Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricGENNEXDIVISLAB
Last 12-Month Dividend i₹0.00₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend i₹0.00₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends i₹0.00₹150.00
Ex-Dividend DateN/AJul 25, 2025